Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak

NCT04351399 | Completed

• 2 other identifiers: 2020_292020-A00907-32
• Study Type: observational
• Target: 318
• Locations: 1 country
• Sites: 1

Brief Summary

Clinical data about psychological impact of quarantine are well studied in transient event or more prolonged situation like jail incarceration. In recent metaanalysis, psychological impact of quarantine was well documented in a specific population during first SARS epidemy. Even after the end of quarantine several patients were still with symptom of avoiding mainly agoraphobia, frequent hand washing and a carefull return to normal life COVID-19 infection is already associated with psychological symptom like anxiety, depression, sleep disorders and symptoms of acute stress However psychological impact of quarantine is on none in chronic painful inflammatory rheumatism in France. The prevalence of rheumatoid arthritis is 0.5% of the population with frequent comorbidity such as anxiety and depression. During the quarantine secondary to COVID-19 pandemic it's possible to evaluated the psychological impact of adult RA patients. The present study is an "emergency" being realize before the end of the quarantine.

Conditions

Sars-CoV2; Rheumatic Diseases; Rheumatoid Arthritis; Chronic Pain

Keywords

Psychological impact; COVID-19; Rheumatoid arthritis

Outcome Measures

Primary Outcomes (1)

• Frequency of RA patients with emotional impact (feeling of isolation)

  maximum 1 week from baseline on

Secondary Outcomes (1)

• self-reported questionnaire for painful

  maximum 1 week from baseline on

Study Arms (1)

patient with chronic painful inflammatory rheumatism

Other: questionnaire assesment

Interventions

questionnaire assesment OTHER

The questionnaire will ask questions around their socio-demographic characteristics,quality of life, painful, using analgesic , since they are in quarantine

patient with chronic painful inflammatory rheumatism

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

RA patient will be interviewed par internet questionnaire (patient association / ANDAR)

You may qualify if:

• Rheumatoid arthritis Quarantine

You may not qualify if:

• Non adult patient RA patient without quarantine

Sponsors & Collaborators

• University Hospital, Lille: lead

Study Sites (1)

Hopital Roger Salengro, CHU Lille

Lille, 59037, France

Location

MeSH Terms

Conditions

Rheumatic Diseases; Arthritis, Rheumatoid; Chronic Pain; COVID-19

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Arthritis; Joint Diseases; Autoimmune Diseases; Immune System Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• René-Marc FLIPO, MD,PhD

  University Hospital, Lille

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: FAMILY BASED
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 14, 2020
• First Posted: April 17, 2020
• Study Start: April 27, 2020
• Primary Completion: May 4, 2020
• Study Completion: May 4, 2020
• Last Updated: December 11, 2020

Record last verified: 2020-04

Locations

FR (1)